滤泡性淋巴瘤
肿瘤微环境
免疫系统
医学
间质细胞
癌症研究
免疫检查点
淋巴瘤
调节器
基因表达谱
疾病
恶性肿瘤
免疫学
免疫疗法
精密医学
计算生物学
套细胞淋巴瘤
生物信息学
基质
T细胞
系统生物学
生物
卵泡期
生物标志物发现
电池类型
细胞
作者
Zhi‐Zhang Yang,Stephen M. Ansell
标识
DOI:10.1080/1744666x.2026.2731956
摘要
INSTRUCTION: Follicular lymphoma (FL) is an indolent B cell malignancy characterized by recurrent genetic alterations, yet its clinical course is highly variable and not fully explained by tumor-intrinsic features alone. Increasing evidence highlights the tumor microenvironment (TME) as a critical regulator of disease progression, therapeutic response, and immune escape. AREAS COVERED: FL TME is composed of diverse cellular elements, including T cell subsets, tumor-associated macrophages, stromal cells, and follicular dendritic cells, which collectively provide survival signals and shape immune dysfunction. These interactions have led to the identification of potential therapeutic targets, such as immune checkpoint molecules, macrophage polarization pathways, and stromal-tumor signaling axes. In parallel, microenvironment-derived biomarkers, including specific immune cell compositions, spatial organization patterns, and gene expression signatures, are emerging as important predictors of prognosis and treatment outcomes. Advances in single-cell and spatial profiling technologies have further refined our understanding of TME heterogeneity, enabling the discovery of clinically relevant targets and biomarkers. EXPERT OPINION: Together, these insights support a more integrated model of FL biology and provide a foundation for developing microenvironment-directed therapies and precision medicine approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI